Some of the most exciting medtech innovations are in the digital space. If they come to Europe later than they should because of uncertainty about the AI Act, then that is going to be a “huge, missed opportunity” for patients and healthcare systems in Europe.
That is the view of Oliver Bisazza, CEO of MedTech Europe, during an interview with Medtech Insight during the first...
Welcome to HBW Insight
Create an account to read this article
Already a subscriber?